Corvus Pharmaceuticals Inc.

NASDAQ: CRVS
Share price (12/15/25): $8.39
Market cap (12/15/25): $627 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Jones William Benton

Miller Richard a MD

News Filter

Provides Business Update and Reports Third Quarter 2025 Financial Results

Change in Directors, Officers or Compensation

Provides Business Update and Reports Second Quarter 2025 Financial Results

Shareholder Vote Results

Announces Full Data From Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC